Cargando…
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease
INTRODUCTION: Fecal calprotectin (FC) is a noninvasive tool for examining response to biologics in inflammatory bowel disease (IBD), but its performance in relation to other novel fecal markers of various cellular origins is unknown. METHODS: We performed a prospective multicenter cohort study and i...
Autores principales: | Ling Lundström, Maria, Peterson, Christer, Lampinen, Maria, Hedin, Charlotte R. H., Keita, Åsa V., Kruse, Robert, Magnusson, Maria K., Lindqvist, Carl Mårten, Repsilber, Dirk, D'Amato, Mauro, Hjortswang, Henrik, Strid, Hans, Rönnblom, Anders, Söderholm, Johan D., Öhman, Lena, Venge, Per, Halfvarson, Jonas, Carlson, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462075/ https://www.ncbi.nlm.nih.gov/pubmed/37256716 http://dx.doi.org/10.14309/ctg.0000000000000605 |
Ejemplares similares
-
Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022) -
Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles
por: Andersson, Erik, et al.
Publicado: (2017) -
Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids
por: Mattsson, Gustav, et al.
Publicado: (2017) -
Gut Barrier Dysfunction—A Primary Defect in Twins with Crohn’s Disease Predominantly Caused by Genetic Predisposition
por: Keita, Åsa V, et al.
Publicado: (2018) -
Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register
por: Thunberg, Joel, et al.
Publicado: (2022)